Library
MPPP
Desmethylprodine or 1-methyl-4-phenyl-4-propionoxypiperidine is an opioid analgesic drug developed in the 1940s by researchers at Hoffmann-La Roche. Desmethylprodine has been labeled by the DEA as a Schedule I drug in the United States. It is an analog of pethidine (meperidine), a Schedule II drug. Chemically, it is a reversed ester of pethidine which has about 70% of the potency of morphine. Unlike its derivative prodine, it does not exhibit optical isomerism. It was reported to have 30 times the activity of pethidine and a greater analgesic effect than morphine in rats, and it was demonstrated to cause central nervous system stimulation in mice.
Also known as: Desmethylprodine, 1-Methyl-4-phenyl-4-propionoxypiperidine (MPPP)
Classification
- Chemical: Opioid
- Psychoactive: Depressant
- Tag: Synthetic opioid
Effects
- Sedation
- Motor Impairment
- Respiratory Depression
- Constipation
- Pupil Constriction
- Itchiness
- Reduced Anxiety
- Euphoria
- Anxiety Suppression
- Mood Lift
- Sadness
- Compulsive Redosing
- Dulled Perception
- Decreased Libido
- Double Vision
- Dehydration
- Appetite Suppression
- Increased Music Appreciation
Routes of Administration
No route information available yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
